Abstract:2033 Background: The risk of VTE is very high for patients with brain tumors, with Glioblastoma (GB) considered one of the most at risk cancers. The aim of this study is to describe the occurrence and associated risk factors for the development of VTE among GB (patients) pts. Methods: In this IRB approved retrospective study, our neuro-oncology longitudinal database was screened for pts with GB, who were treated with concurrent radiation and Temozolomide (TMZ) followed by adjuvant TMZ from 2005-2011. 543 pts were identified. Results: 134 (24.6%) pts developed VTE, with 139 documented events. 56 pts (42%) were diagnosed with deep vein thrombosis (DVT) , 27 pts (20%) with pulmonary emboli (PE) with no evidence of DVT, and 51 pts (38%) had both DVT and PE. The majority were diagnosed after starting adjuvant TMZ (61%) with a median time of 6.5 months from starting adjuvant TMZ (range 0.03-120) with only 22 (16%) pts developing VTE before starting post surgery treatment and 32(23%) during chemoradiation. At time of VTE diagnosis, 44 (32%) patients had stable disease, 61 (43%) were clinically or radiographically progressing and the rest were newly diagnosed or during concurrent treatment. 56 (40%) patients were admitted secondary to their VTE. Treatment with anticoagulation alone was given to 68 (52%) pts, IVC filter only was inserted to 6 (5%) pts and 56 (43%)pts were treated with both modalities). 15 pts developed complications secondary to anticoagulation(5 brain haemorrhage , 6 bleeding in other locations and 4 thrombocytopenia). On univariate analysis risk factor associated with development of VTE after starting adjuvant TMZ treatment were: sex, prior history of venous thrombosis, poor KPS, requiring assistive device for ambulation, paresis, high BMI, pre chemotherapy WBC counts, and various medications (including anticoagulation, blood pressure drugs, anti-acid drugs and corticosteroids) (p<0.05). On multivariate analysis sex, poor KPS, high BMI, history of VTE and use of corticosteroids were significant risk factors for the development of VTE (P<0.05). Conclusions: VTE is a common complication of GB and can occur during the course of the disease. Factors associated with increased risk have been identified and will be useful in developing risk models in this patient population.

Venous Thromboembolism in Patients with Glioblastoma: Molecular Mechanisms and Clinical Implications

Venous Thromboembolism (VTE) and Glioblastoma.

Epidemiology, biology, and management of venous thromboembolism in gliomas: An interdisciplinary review

A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors

Circulating Tumor Cells and Thromboembolic Events in Patients with Glioblastoma

Clinical and molecular determinants of bleeding-related adverse outcomes in high-grade glioma

Glycemia and Coagulation in Patients with Glioblastomas

Clinical and Genetic Markers of Vascular Toxicity in Glioblastoma Patients: Insights from NRG Oncology RTOG-0825

RNA-sequencing to discover genes and signaling pathways associated with venous thromboembolism in glioblastoma patients: A case-control study

Role of circulating mitochondria in venous thrombosis in glioblastoma

Abstract C080: Glioma cell-mediated hyper-thrombotic tumor microenvironment drives glioblastoma growth

Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles

The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab

Venous Thromboembolism in Brain Tumor Patients

Acute venous thromboembolism in patients with brain cancer: clinical course

How I Treat acute venous thromboembolism in patients with brain tumors

Combined analysis of clinical and laboratory markers to predict the risk of venous thromboembolism in patients with IDH1 wild-type glioblastoma

Clinical and translational advances in primary brain tumor therapy with a focus on glioblastoma-A comprehensive review of the literature

Neutrophil extracellular traps induce a hypercoagulable state in glioma

Anticoagulant therapy in high grade gliomas: a systematic review on state of the art and future perspectives

Prevalence, Characteristics, and Risk Factors of Venous Thromboembolism in Patients with Brain Tumor Undergoing Craniotomy: a Meta-Analysis.